A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Lineage Cell Therapeutics Inc’s current trading price is -68.68% away from its 52-week high, while its distance from the 52-week low is 4.84%. The
The market performance of Lineage Cell Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.61 on 03/28/24, while the lowest value for the same duration was $0.48 on 12/17/24. 52-week price history
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -46.78%.However, over the last six months, we can see a stronger performance of -37.56%. Over
The market performance of Lineage Cell Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $1.61 on 03/28/24, with the lowest value for the same timeframe being $0.50, recorded on 11/22/24. 52-week price history of LCTX Stock
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lineage Cell Therapeutics Inc’s current trading price is -68.70% away from its 52-week high, while its distance from the 52-week low is
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Lineage Cell Therapeutics Inc’s current trading price is -56.52% away from its 52-week high, while its distance from the 52-week
All rights reserved © 2024, Powered By Smart TechOne
